SPE-HPLC法测定马破伤风免疫球蛋白F(ab’)2中TritonX-100残留量
Determination of Triton X-100 residues in the equine antitetanus immunoglobulin F(ab’)2by SPE-HPLC
分类号:
出版年·卷·期(页码):2014,34 (7):0-0
DOI:
10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------
目的:建立固相萃取高效液相色谱(SPE-HPLC)法测定马破伤风免疫球蛋白F(ab’)2中灭活剂Triton X-100的残留量。 方法:采用Oasis固相萃取小柱对样品进行预处理,以水和5%甲醇为淋洗剂,以甲醇为洗脱剂,收集甲醇洗脱物用于HPLC分析。采用ZORBAX Extend-C18色谱柱(4.6 mm×150 mm,5 μm),流动相为甲醇-水(80:20),流速1.0 mL·min-1,检测波长230 nm,柱温30℃,进样量10 μL。 结果:Triton X-100浓度在0.56~55.34 μg·mL-1范围内,与峰面积线性关系良好(r=0.9998);检测限(S/N=3)为2.03 ng,定量限(S/N=10)为4.06 ng;提取回收率为91.8%。 结论:本方法操作简便、准确、重复性好,可用于Triton X-100的残留量测定。
-----英文摘要:---------------------------------------------------------------------------------------
Objective: To establish a SPE-HPLC method for the determination of Triton X-100 residues in equine antitetanus immunoglobulin F(ab')2. Methods: Samples were pre-treated on Oasis HLB SPE column,then cleaned-up by water and 5% methanol,and finally extracted by methanol.The analysis of extracts was performed on a ZORBAX Extend-C18 column(4.6 mm×150 mm,5 μm)with a mobile phase consisting of methanol-water(80: 20,v/v)at a flow rate of 1.0 mL·min-1.The column temperature was set at 30℃ and the injection volume was 10 μL.Triton X-100 was detected at the wavelength of 230 nm with a DAD detection. Results: The established HPLC method resulted in sharp and symmetric peaks of Triton X-100,whereas the calibration curve of Triton X-100 displayed a good linearity within the concentration of 0.56-55.34 μg·mL-1(r=0.9998).The LOD and LOQ were 2.03 ng and 4.06 ng,respectively.Specificity,precision,accuracy,stability and robustness were acceptable.The extraction recovery was 91.8%. Conclusion: The results indicate that the established method is convenient,accurate and reproducible,which can be used in the analysis of Triton X-100 residues in equine antitetanus immunoglobulin F(ab')2.
-----参考文献:---------------------------------------------------------------------------------------
欢迎阅读《药物分析杂志》!您是该文第 879位读者!